| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 18 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 3 | DOXORUBICIN | 16 |
| 4 | PEMBROLIZUMAB | 16 |
| 5 | PREDNISONE | 15 |
| 6 | CAPECITABINE | 14 |
| 7 | IBUPFROFEN | 12 |
| 8 | IBUPROFEN | 12 |
| 9 | IBUPROFEN 200 MG | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIFILEUCEL | 1 | 0.0035 |
| 1 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 2 | 0.0014 |
| 2 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 3 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 4 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 5 | OXACILLIN SODIUM | 1 | 0.0009 |
| 6 | ARGATROBAN | 1 | 0.0007 |
| 7 | ZOLBETUXIMAB | 1 | 0.0007 |
| 8 | HYALURONATE SODIUM | 1 | 0.0007 |
| 9 | ENTRECTINIB | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 29 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 26 |
| 3 | Platinum-based Drug [EPC] | 22 |
| 4 | Alkylating Drug [EPC] | 21 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 12 |
| 9 | Benzodiazepine [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 26 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 6 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 7 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 8 | Antimalarial [EPC] | 2 | 0.0002 |
| 9 | Antiprotozoal [EPC] | 2 | 0.0002 |